Literature DB >> 26037293

Comparison of Coronary Computed Tomographic Angiographic Findings in Asymptomatic Subjects With Versus Without Diabetes Mellitus.

Gyung-Min Park1, Jae-Hwan Lee2, Seung-Whan Lee3, Sung-Cheol Yun4, Young-Hak Kim5, Young-Rak Cho6, Eun Ha Gil1, Tae-Seok Kim1, Chan Joon Kim1, Jung Sun Cho1, Mahn-Won Park1, Sung Ho Her1, Dong Hyun Yang7, Joon-Won Kang7, Tae-Hwan Lim7, Eun Hee Koh8, Woo Je Lee8, Min-Seon Kim8, Ki-Up Lee8, Hong-Kyu Kim9, Jaewon Choe9, Joong-Yeol Park8.   

Abstract

There are limited data on the impact of diabetes mellitus (DM) on the risk of subclinical atherosclerosis. Therefore, we sought to investigate the impact of DM on the risk of subclinical atherosclerosis in asymptomatic subjects. We analyzed 2,034 propensity score-matched asymptomatic subjects who underwent coronary computed tomographic angiography (mean age 55.9 ± 8.2 years; men 1,725 [84.8%]). Coronary artery calcium score, degree and extent of coronary artery disease (CAD), and clinical outcomes were assessed. High-risk CAD was defined as at least 2-vessel coronary disease with proximal left anterior descending artery involvement, 3-vessel disease, or left main disease. Compared with subjects without DM, those matched with DM had higher coronary artery calcium score (89.9 ± 240.4 vs 62.8 ± 179.5, p = 0.004) and more significant CAD (≥50% diameter stenosis, 15.2% vs 10.2%, p = 0.001), largely in the form of 1-vessel disease (10.8% vs 7.3%, p = 0.007). However, there were no significant differences between matched pairs in significant CAD in the left main or proximal left anterior descending artery (5.3% vs 3.8%, p = 0.138), multivessel disease (4.4% vs 2.9%, p = 0.101), and high-risk CAD (4.3% vs 2.7%, p = 0.058). During the follow-up period (median 21.8, interquartile range 15.2 to 33.4 months), there was no significant difference in the composite of all-cause death, myocardial infarction, acute coronary syndrome, and coronary revascularization between 2 groups (hazard ratio 1.438, 95% confidence interval 0.844 to 2.449, p = 0.181). In asymptomatic subjects, those matched with DM have more subclinical atherosclerosis, mainly confined to non-high-risk CAD, than those matched without DM, and there are no differences in high-risk CAD and clinical outcomes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26037293     DOI: 10.1016/j.amjcard.2015.04.046

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Non-invasive imaging in assessment of the asymptomatic diabetic patient: Is it of value?

Authors:  Daniel S Berman; Matthew J Budoff; James K Min; Paolo Raggi; Alan Rozanski; Leslee Shaw; Prem Soman
Journal:  J Nucl Cardiol       Date:  2015-08-12       Impact factor: 5.952

2.  Screening asymptomatic patients with type 2 diabetes: The debates persist.

Authors:  George A Beller; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2015-09-21       Impact factor: 5.952

3.  Association between coronary artery atherosclerosis and plasma glucose levels assessed by dual-source computed tomography.

Authors:  Yi Yu; Zhiwen Zhou; Kun Sun; Lili Xi; Lina Zhang; Lingwei Yu; Jing Wang; Jiayi Zheng; Ming Ding
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

Review 4.  Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging.

Authors:  Arnold C T Ng; Victoria Delgado; Barry A Borlaug; Jeroen J Bax
Journal:  Nat Rev Cardiol       Date:  2020-11-13       Impact factor: 32.419

5.  Impact of Diabetes Control on Subclinical Atherosclerosis: Analysis from Coronary Computed Tomographic Angiography Registry.

Authors:  Gyung Min Park; Chang Hoon Lee; Seung Whan Lee; Sung Cheol Yun; Young Hak Kim; Yong Giun Kim; Ki Bum Won; Soe Hee Ann; Shin Jae Kim; Dong Hyun Yang; Joon Won Kang; Tae Hwan Lim; Eun Hee Koh; Woo Je Lee; Min Seon Kim; Joong Yeol Park; Hong Kyu Kim; Jaewon Choe; Sang Gon Lee
Journal:  Diabetes Metab J       Date:  2019-11-22       Impact factor: 5.376

Review 6.  Cardiovascular Screening for the Asymptomatic Patient with Diabetes: More Cons Than Pros.

Authors:  Konstantinos Makrilakis; Stavros Liatis
Journal:  J Diabetes Res       Date:  2017-12-14       Impact factor: 4.011

Review 7.  Diabetes and Subclinical Coronary Atherosclerosis.

Authors:  Chang Hoon Lee; Seung Whan Lee; Seong Wook Park
Journal:  Diabetes Metab J       Date:  2018-10       Impact factor: 5.376

8.  Homocysteine is not a risk factor for subclinical coronary atherosclerosis in asymptomatic individuals.

Authors:  Sangwoo Park; Gyung-Min Park; Jinhee Ha; Young-Rak Cho; Jae-Hyung Roh; Eun Ji Park; Yujin Yang; Ki-Bum Won; Soe Hee Ann; Yong-Giun Kim; Shin-Jae Kim; Sang-Gon Lee; Dong Hyun Yang; Joon-Won Kang; Tae-Hwan Lim; Hong-Kyu Kim; Jaewon Choe; Seung-Whan Lee; Young-Hak Kim
Journal:  PLoS One       Date:  2020-04-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.